Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Express Scripts
Medtronic
Boehringer Ingelheim
Baxter

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,949,986

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,949,986 protect, and when does it expire?

Patent 9,949,986 protects KYBELLA and is included in one NDA.

This patent has fifty-seven patent family members in twenty-eight countries.

Summary for Patent: 9,949,986
Title:Synthetic bile acid compositions and methods
Abstract: Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
Inventor(s): Moriarty; Robert M. (Calabasas, CA), David; Nathaniel E. (Calabasas, CA), Mahmood; Nadir Ahmeduddin (Calabasas, CA)
Assignee: Kythera Biopharmaceuticals, Inc. (Parsippany, NJ)
Application Number:15/349,573
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,949,986
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,949,986

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes   Start Trial   Start Trial IMPROVEMENT IN THE APPEARANCE OF MODERATE TO SEVERE CONVEXITY OR FULLNESS ASSOCIATED WITH SUBMENTAL FAT IN ADULTS BY MEANS OF REDUCING SUBMENTAL FAT VOLUME AS DESCRIBED IN THE APPROVED LABELING   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Harvard Business School
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.